Opinion in 2008

Filter By:

Article Type
Year
  • The function of protein deacetylase SIRT1 in cancer is controversial: it has been shown to have oncogenic properties as well as tumour suppressor activity. How might these opposing functions be explained?

    • Christopher L. Brooks
    • Wei Gu
    Opinion
  • Which breast tumours does the term 'basal-like' best describe? In this Perspective the author argues that this term is misleading and explains why by use of current understanding of breast cancer pathology.

    • Barry Gusterson
    Opinion
  • The development of cancer has been associated with microbial infection, injury, inflammation and tissue repair. This Perspective discusses how the function of the Toll-like receptors may relate to these processes in the context of carcinogenesis.

    • Seth Rakoff-Nahoum
    • Ruslan Medzhitov
    Opinion
  • DNA double strand breaks (DSBs) may lead to cancer but, paradoxically, are also used to kill cancer cells. How might γH2AX — a surrogate marker of DSBs — be used to detect precancerous cells, to stage cancers, to monitor the effectiveness of cancer therapies and to develop novel anticancer drugs?

    • William M. Bonner
    • Christophe E. Redon
    • Yves Pommier
    Opinion
  • Ageing is thought to be associated with increased oxidative stress and increased cancer risk. However, recent evidence that breast cancers arising in older women are not associated with oxidative stress questions the link between age and increasing oxidative stress. Does ageing cause or simply permit cancer development?

    • Christopher C. Benz
    • Christina Yau
    Opinion
  • Recent data indicates an anti-angiogenic function for a new class of VEGF-A isoforms. In this Opinion article, Steven Harper and David Bates discuss the emerging role of these proteins in tumourigenesis and anti-angiogenic therapeutic strategies.

    • Steven J. Harper
    • David O. Bates
    Opinion
  • In patients with advanced cancer, pro-inflammatory cytokines are associated with anorexia and cachexia, pain, fatigue, depression, toxicity of treatment and resistance to treatment. What is our current understanding of the pathways that mediate these effects and how can we prevent them?

    • Bostjan Seruga
    • Haibo Zhang
    • Ian F. Tannock
    Opinion
  • High mammographic density (MD) is an established risk factor for breast cancer. In theory, the number of genes that regulate MD should be smaller than that influencing breast cancer risk. How informative have the initial studies of the genetics of MD proved to be?

    • Linda E. Kelemen
    • Thomas A. Sellers
    • Celine M. Vachon
    Opinion
  • Mutations in the bone morphogenetic protein pathway have been found in juvenile polyposis, an inherited polyposis syndrome that predisposes to colorectal cancer. What relevance do these findings have to sporadic cases of colorectal cancer?

    • James C. Hardwick
    • Liudmila L. Kodach
    • Gijs R. van den Brink
    Opinion
  • Although RB was first identified as a tumour suppressor over 20 years ago, the implications of RB loss for tumour biology remain enigmatic. This Perspective discusses how context-specific consequences of RB inactivation might influence the response of a tumour to a range of therapeutic agents.

    • Erik S. Knudsen
    • Karen E. Knudsen
    Opinion
  • Of the two main urokinase plasminogen activator inhibitors, high tumour levels of the type 1 inhibitor promote tumour progression, whereas high levels of the type 2 inhibitor decrease tumour growth and metastasis. What might be the basis of this paradoxical action?

    • David R. Croucher
    • Darren N. Saunders
    • Marie Ranson
    Opinion
  • Cancer stem cell content and the intrinsic radiosensitivity of cancer stem cells is thought to vary between tumours, thereby affecting their radiocurability. What do we know about cancer stem cells in radioresistance and how might this information be used?

    • Michael Baumann
    • Mechthild Krause
    • Richard Hill
    Opinion
  • To achieve a comprehensive mechanistic view of the cancer process do we need to assemble a physically integrated team of interdisciplinary scientists that includes mathematicians? This Perspective discusses the useful insights provided by such an interaction.

    • Alexander R. A. Anderson
    • Vito Quaranta
    Opinion
  • The discovery that the oncogene MYC can stimulate differentiation rather than proliferation in human epidermal stem cells was, understandably, greeted with scepticism. However, subsequent studies have revealed important concepts that are relevant to the function of MYC in tumorigenesis.

    • Fiona M. Watt
    • Michaela Frye
    • Salvador Aznar Benitah
    Opinion
  • This Perspective provides an intriguing look at cell competition, which was originally described inDrosophila melanogastermore than 30 years ago. How do cells compete with one another, and how might this process relate to cancer?

    • Eduardo Moreno
    Opinion
  • This Perspective considers the differences between the hypoxia-inducible factor (HIF)–MYC transcriptional network that operates under normal homeostatic conditions and the network that operates in a tumorigenic milieu.

    • Chi V. Dang
    • Jung-whan Kim
    • Jason Yustein
    Opinion